GLP-1 drugs are tempting
The dropout rate, which the cultural narrative tends to elide, is significant, somewhere between 10% and 25% of patients discontinue within the first year, the majority due to gastrointestinal side effects that for some are tolerable nuisance and for others are quality-of-life-destroying
By contrast, danuglipron had no effect on HFD-evoked dopamine release in WT mice (Extended Data Fig
Ferritin level improvements and transferrin saturation normalization are also faster with liposomal supplements
Chen HH, Sue YM, Chen CH, Hsu YH, Hou CC, Cheng CY, Lin SL, Tsai WL, Chen TW, Chen TH: Peroxisome proliferator-activated receptor alpha plays a crucial role in L-carnitine anti-apoptosis effect in renal tubular cells
Medical contraindications and usewithcaution groups Even if regulators dont ban it outright, clinicians and safetyreview papers suggest avoiding or proceeding with extreme caution if you have: Active pancreatitis or high risk of pancreatitis Preclinical work links some GLP1like pathways (relevant to BPC157 formulations) with pancreatitis risk